Page 75 - JCTR-10-1
P. 75

Zhuang et al. | Journal of Clinical and Translational Research 2024; 10(1): 62-71   71
             Treatment and Survival of Extremity Soft Tissue Sarcoma.   Treatment Options for Advanced Liposarcoma. Oncol Res
             Ann Oncol 2014;25:725-9.                                 Treat 2022;45:525-43.
             doi: 10.1093/annonc/mdt583                               doi: 10.1159/000524939
        [37]  Zhang SL, Wang WR, Liu ZJ, Wang ZM. Marital Status   [43]  Salduz  A,  Alpan  B,  Valiyev  N,  Ozmen  E,  Iribas  A,
             and  Survival  in  Patients  with  Soft  Tissue  Sarcoma:  A   Agaoglu F, et al. Neoadjuvant Radiotherapy for Myxoid
             Population-based, Propensity-Matched Study. Cancer Med   Liposarcomas: Oncologic Outcomes and Histopathologic
             2019;8:465-79.                                           Correlations. Acta Orthop Traumatol Turc 2017;51:355-61.
             doi: 10.1002/cam4.1802                                   doi: 10.1016/j.aott.2017.03.009
        [38]  Kobayashi E, Kawai A. Histology-specific Chemotherapy   [44]  von  Mehren  M,  Kane  JM, Agulnik  M,  Bui  MM,  Carr-
             in  Soft-Tissue  Sarcomas.  Gan  To  Kagaku  Ryoho       Ascher  J,  Choy  E,  et al.  Soft  Tissue  Sarcoma,  Version
             2017;44:468-72.                                          2.2022, NCCN Clinical Practice Guidelines in Oncology.
        [39]  Nassif EF, Keung EZ, Thirasastr P, Somaiah N. Myxoid    J Natl Compr Canc Netw 2022;20:815-33.
             Liposarcomas:  Systemic  Treatment  Options.  Curr  Treat      doi: 10.6004/jnccn.2022.0035
             Options Oncol 2023;24:274-91.                      [45]  Bonvalot  S,  Gronchi  A,  Le  Pechoux  C,  Swallow  CJ,
             doi: 10.1007/s11864-023-01057-4                          Strauss D, Meeus P, et al. Preoperative Radiotherapy Plus
        [40]  Nakamura  T,  Sudo A.  The  Role  of  Trabectedin  in  Soft   Surgery Versus Surgery Alone for Patients with Primary
             Tissue Sarcoma. Front Pharmacol 2022;13:777872.          Retroperitoneal  Sarcoma  (EORTC-62092:  STRASS):
             doi: 10.3389/fphar.2022.777872                           A  Multicentre,  Open-Label,  Randomised,  Phase  3  Trial.
        [41]  Kim CG, Sim NS, Kim JE, Yun KH, Lee YH, Kim SH,         Lancet Oncol 2020;21:1366-77.
             et  al.  Phase  II  Clinical  Trial  of  Eribulin-Gemcitabine      doi: 10.1016/S1470-2045(20)30446-0
             Combination Therapy in Previously Treated Patients with   [46]  Lee LH, Tepper S, Owen G, Wang D, Lopez-Hisijos N,
             Advanced Liposarcoma or Leiomyosarcoma. Clin Cancer      Colman MW, et al. Radiotherapy, Volume Reduction, and
             Res 2022;28:3225-34.                                     Short-term Surgical Outcomes in the Treatment of Large
             doi: 10.1158/1078-0432.CCR-22-0518                       Myxoid Liposarcomas. Radiat Oncol J 2022;40:172-9.
        [42]  Schoffski  P.  Established  and  Experimental  Systemic      doi: 10.3857/roj.2022.00094





































                                                                Publisher’s note
                                                                AccScience Publishing remains neutral with regard to jurisdictional
                                                                claims in published maps and institutional affiliations.
                                                 DOI: https://doi.org/10.36922/jctr.00113
   70   71   72   73   74   75   76   77   78   79   80